VEEVClinical Trials•prnewswire•
Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
Sentiment:Positive (70)
Summary
PLEASANTON, Calif., Aug. 28, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in biotechnology, Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 28, 2025 by prnewswire